Get Started in Minutes
How Fulvestrant Copay Assistance Works
1 – Check Your Coverage/Benefits Verification
Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.
2 – Transfer Prescription to AmeriPharma
We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.
3 – Prior Authorization
Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.
4 – Copay Assistance & Financial Aid
We secure financial aid and decrease copays, out-of-pocket expenses, and high deductibles. To date, AmeriPharma Specialty Care has secured $55 million in financial assistance for our patients.
5 – Nursing Care Coordination
AmeriPharma puts your schedule and home environment first when scheduling and coordinating one of our specialized nurses for your in-home infusions.
6 – Delivery Coordination
Medications are always delivered in strict compliance with the specific requirements for immune globulin shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.
What Is Fulvestrant?
Fulvestrant is also known by the brand name, Faslodex. It is an antineoplastic (anti-cancer) drug that belongs to a class called estrogen receptor antagonists. It is an injectable solution that is used to treat locally advanced or metastatic breast cancer in postmenopausal, estrogen receptor-positive women. Fulvestrant is a type of chemotherapy.
What Is Chemotherapy?
Chemotherapy is a cancer treatment in which certain drugs are used to kill cancerous cells. These drugs are usually cytotoxic chemical substances that are toxic to the cells, restrict their growth, prevent their division, and ultimately kill the cells.
How Is Fulvestrant Used?
Fulvestrant has been approved by the Food and Drug Administration (FDA) to treat different types of breast cancers. Fulvestrant can be prescribed in combination with other chemotherapy agents, like palbociclib (Ibrance), abemaciclib (Verzenios), or ribociclib (Kisqali), depending on the severity and type of cancer.
Fulvestrant is only available in the form of an injection to be administered intramuscularly in the buttocks (gluteal) area. Each pre-filled syringe is available as a 5 ml dose which contains 250 mg of fulvestrant. Therefore, each ml contains 50 mg of fulvestrant. Other ingredients included in the injection are ethanol (96%), benzyl alcohol (100 mg/ml), benzyl benzoate, and refined castor oil.
If you have missed a dose of this medication, contact your physician immediately, as this drug should be taken on a regular schedule. Do not attempt to catch up by doubling the dose.
Copay and Financial Assistance
AmeriPharma Specialty Care alleviates financial burdens for patients and their families
Advanced software locates funding sources to match you with top-dollar foundation programs
One of our copay assistance specialists will assist with the application process
Automatic updates will be sent to you and your physician on the status of the funding
Fulvestrant Side Effects
Common side effects include:
- Gastrointestinal (GI) effects
- Injection site pain
- Allergic reaction/hypersensitivity
- Hormonal side effects
- Throat irritation
- Flu-like symptoms
- Urinary tract infection (UTI)
- Leg weakness
- Bruising or bleeding
- Chest pain
- Swelling of arms or legs
Directions for Use
Fulvestrant may be taken without regard to food. The pre-filled syringe of fulvestrant is supposed to be used for intramuscular injection into the buttocks (gluteal) area only. It should never be administered intravenously, subcutaneously, or intra-arterially. Two pre-filled syringes (250 mg per 5 ml) should be administered, one in each buttock, slowly over 1 to 2 minutes per injection. Do not administer more than 5 ml per buttock.
To prepare each syringe for administration, hold the syringe upright, carefully tilt the syringe cap back and forth (without twisting) until the cap disconnects for removal. Pull the cap off by pulling up without touching the syringe tip (to maintain sterility), attach safety needle to syringe tip, and twist firmly to lock. Remove needle cap by pulling straight off to avoid damaging needlepoint, remove needle sheath and expel excess air from the syringe before administration. Refer to the product labeling for more detailed instructions.
Fulvestrant is initially given as 500 mg on days 1, 15, and 29, and then dosed 500 mg once every 4 weeks for maintenance. The dose is dependent on the cancer type and severity. Verify the correct dose and frequency with your provider. The dose should not be more or less than what is prescribed.